NAPLEX practice question 17 of 25

Which of the following statements is true regarding Drug-receptor bonds?

Full set: 154 questions

Domain Ensure Safe and Effective Pharmacotherapy and Health Outcomes

Answer options
A: Covalent bonds of drugs with receptors are strong and mostly reversible
B: Covalent bonding is much more common than electrostatic bonding in drug-receptor interactions
C: Electrostatic bonds are stronger than covalent bonds
D: Hydrophobic bonds are weak bonds and they are important in the interactions of highly water soluble drugs with the lipids of cell membranes
E: Bond formation of between the acetyl group of aspirin and cyclo-oxygenase enzyme is a covalent bond Correct answer
Correct Answer:
E. Bond formation of between the acetyl group of aspirin and cyclo-oxygenase enzyme is a covalent bond
Explanation

The mechanism of action of aspirin involves the irreversible inhibition of the cyclo-oxygenase (COX) enzyme. Aspirin transfers its acetyl group to a serine residue in the active site of the COX enzyme. This acetylation reaction forms a stable covalent bond, which permanently inactivates the enzyme molecule. This is a classic and frequently cited example of a drug forming a covalent bond with its target receptor (in this case, an enzyme), leading to a long-lasting pharmacological effect.

Why Incorrect

A. Covalent bonds are the strongest type of drug-receptor bond and are typically considered irreversible or very slowly reversible, not "mostly reversible."
B. Weaker, reversible interactions such as electrostatic, hydrogen, and van der Waals bonds are far more common in drug-receptor binding than strong covalent bonds.
C. Covalent bonds, which involve the sharing of electrons between atoms, are significantly stronger than electrostatic bonds, which are based on the attraction between opposite charges.
D. Hydrophobic interactions are important for the binding of lipid-soluble (lipophilic) drugs to nonpolar regions of receptors, not for highly water-soluble (hydrophilic) drugs.

References

1. Brunton

L. L.

Hilal-Dandan

R.

& Knollmann

B. C. (Eds.). (2018). Goodman & Gilman's The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill.

Chapter 3

"Pharmacodynamics: Molecular Mechanisms of Drug Action

" Section: "Receptors

" Sub-section: "Drug-Receptor Bonds

" describes covalent bonds as strong and typically irreversible.

Chapter 38

"Anti-Inflammatory

Antipyretic

and Analgesic Agents

" Section: "Aspirin and Other Salicylates

" details the mechanism of aspirin

stating it "irreversibly acetylates cyclooxygenase" via a covalent bond.

2. Katzung

B. G. (Ed.). (2018). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill.

Chapter 2

"Drug Receptors & Pharmacodynamics

" Section: "The Nature of Receptors

" discusses the types of drug-receptor bonds

noting that covalent bonds are strong and often result in irreversible action.

Chapter 36

"Nonsteroidal Anti-Inflammatory Drugs

" Section: "Aspirin

" explicitly states

"Aspirin is a nonselective COX inhibitor; it irreversibly inhibits COX-1 and COX-2 by covalent acetylation of a serine residue in the active site of the enzyme."

3. University of California

San Francisco (UCSF) School of Pharmacy. (n.d.). Pharmacodynamics I: Drug-Receptor Interactions [Courseware]. In this material

the hierarchy of bond strengths is established (Covalent > Electrostatic > Hydrogen > Hydrophobic > Van der Waals)

and the rarity and irreversible nature of covalent bonds in pharmacology are highlighted.

Scroll to Top